Role of no synthase in the development of Trypanosoma craz/-induced cardiomyopathy in mice

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 782-787

  Durand, Jorge L ^a,b,c   Mukherjee, Shankar ^a,b,c   Commodari, Fernando ^a,b,c,d   De Souza, Andrea P ^a,b,c   Zhao, Dazhi ^a,b,c   Machado, Fabiana S ^a,b,c   Tanowitz, Herbert B ^a,b,c   Jelicks, Linda A ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d and Chief Scientific Officer   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; ISOENZYME; NOS1 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; NOS3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; HEART SIZE; INFECTION; INFLAMMATION; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; WILD TYPE; ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

LATES; MUS; TRYPANOSOMA; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS CARDIOMYOPATHY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; TRYPANOSOMA CRUZI;

EID: 66149158195     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.782     Document Type: Article

References (40)

1. World Health Organization, 2002. Report on Chagas' Disease. Geneva: World Health Organization.
2. Carod-Artal FJ, 2006. Chagas cardiomyopathy and ischemic stroke. Expert Rev Cardiovasc Ther 4:119-130.
3. Jelicks LA, Shirani J, Wittner M, Chandra M, Weiss LM, Factor SM, Bekirov I, Braunstein VL, Chan J, Huang H, Tanowitz HB, 1999. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease. Am J Trop Med Hyg 61: 207-214.
4. Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, Factor SM, Weiss LM, Braunstein VL, Bacchi CJ, Yarlett N. Chandra M, Shirani J. Tanowitz HB, 1999. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 31: 75-88.
5. Jelicks LA, Chandra M, Shirani J, Shtutin V, Tang B, Christ GJ, Factor SM, Wittner M, Huang H, Weiss LM, Mukherjee S, Bouzahzah B, Petkova SB, Teixeira MM, Douglas SA, Loredo ML, D'Orleans-Juste P, Tanowitz HB, 2002. Cardioprotective effects of phosphoramidon on myocardial structure and func-tion in murine Chagas' disease. Int J Parasiiol 32:1497-1506.
6. Chandra M, Shirani J, Shtutin V, Weiss LM, Factor SM, Petkova SB. Rojkind M, Dominguez-Rosales JA, Jelicks LA, Morris SA, Wittner M, Tanowitz HB, 2002. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study. Int J Parasitol 32:207-215.
7. Lima ES, Andrade ZA, Andrade SG, 2001. TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi. Int J Exp Pathol 82: 327-336.
8. Silva JS, Machado FS, Martins GA, 2003. The role of nitric oxide in the pathogenesis of Chagas disease. Front Biosci 8: s314-s325.
9. Funakoshi H, Kubota T, Machida Y, Kawamura N, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A, 2002. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 282: H2159-H2166.
10. Goren N, Leiros CP, Sterin-Borda L, Borda E, 1998. Nitric oxide synthase in experimental autoimmune myocarditis dysfunction. J Mol Cell Cardiol 30:2467-2474.
11. Li W, Mital S, Ojaimi C, Csiszar A, Kaley G, Hintze TH, 2004. Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J Mol Cell Cardiol 37:671-680.
12. Moncada S, Palmer RM, Higgs EA, 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
13. Amezcua JL, Palmer RM, de Souza BM, Moncada S, 1989. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br I Pharmacol 97: 1119-1124.
14. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM, 1994. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267: H1804-H1813.
15. Klabunde RE, Ritger RC, Helgren MC, 1991. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Eur I Pharmacol 199: 51-59.
16. Bassenge E, 1991. Endothelium-mediated regulation of coronary tone. Basic Res Cardiol 86 (Suppl 2): 69-76.
17. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW, 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91:2314-2319.
18. Gyurko R, Kuhlencordt P, Fishman MC, Huang PL, 2000. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol 278: H971-H981.
19. Suto N, Mikuniya A, Okubo T, Hanada H, Shinozaki N, Okumura K, 1998. Nitric oxide modulates cardiac contractility and oxy-gen consumption without changing contractile efficiency. Am J Physiol 275: H41-H49.
20. Sumeray MS, Rees DD, Yellon DM, 2000. Infarct size and nitric oxide synthase in murine myocardium. J Mol Cell Cardiol 32: 35-42. '
21. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC, 1999. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96:657-662.
22. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB, 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094.
23. Mungrue IN, Husain M, Stewart DJ, 2002. The role of NOS in heart failure: lessons from murine genetic models. Heart Fail Rev 7:407-422.
24. Dawson D, Lygate CA, Zhang MH, Hulbert K, Neubauer S, Casadei B, 2005. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112: 3729-3737.
25. Chandrasekar B, Melby PC, Troyer DA, Freeman GL, 2000. Differential regulation of nitric oxide synthase isoforms in experimental acute chagasic cardiomyopathy. Clin Exp Immunol 121:112-119.
26. Ny L, Li H, Mukherjee S, Persson K, Holmqvist B, Zhao D, Shtutin V, Huang H, Weiss LM, Machado FS, Factor SM, Chan J, Tanowitz HB, Jelicks LA, 2008. A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase. Am J Trop Med Hyg 79: 760-767.
27. Durand JL, Tang B, Gutstein DE, Petkova S, Teixeira MM, Tanowitz HB, Jelicks LA, 2006. Dyskinesis in Chagasic myocar-dium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. Magn Reson Imaging 24: 1051-1057.
28. De Souza AP, Cohen AW, Park DS, Woodman SE, Tang B, Gutstein DE, Factor SM, Tanowitz HB, Lisanti MP, Jelicks LA, 2005. MR imaging of caveolin gene-specific alterations in right ventricu-lar wall thickness. Magn Reson Imaging 23: 61-68.
29. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP, 2002. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactiva-tion of the p42/44 MAPK cascade. I Biol Chem 277: 38988-38997.
30. Chandra M, Tanowitz HB, Petkova SB, Huang H, Weiss LM, Wittner M, Factor SM, Shtutin V, Jelicks LA, Chan J, Shirani J, 2002. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol 32: 897-905.
31. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS, 2000. Trypanosoma crazi-infected cardiomyocytes pro-duce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102: 3003-3008.
32. Machado FS, Souto JT, Rossi MA, Esper L, Tanowitz HB, Aliberti J, Silva JS, 2008. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 10: 1558-1566.
33. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL. Jones RC, Picard MH, Zapol WM, 1998. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide syn-thase 3. J Clin Invest 101:2468-2477.
34. Yang XP, Liu YH, Shesely EG, Bulagannawar M, Liu F, Carretero OA, 1999. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension 34: 24-30.
35. Buys ES, Raher MJ, Blake SL, Neilan TG, Graveline AR, Passeri JJ, Llano M, Perez-Sanz TM, Ichinose F, Janssens S, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M, 2007. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. Am Physiol Heart Circ Physiol 293: H620-H627.
36. Casadei B, 2006. The emerging role of neuronal nitric oxide syn-thase in the regulation of myocardial function. Exp Physiol 91: 943-955.
37. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM, 2002. Nitric oxide regulates the heart by spatial confine-ment of nitric oxide synthase isoforms. Nature 416: 337-339.
38. Ziolo MT, Kohr MJ, Wang H, 2008. Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol 45: 625-632.
39. Petkova SB, Tanowitz HB, Magazine HI, Factor SM, Chan J, Pestell RG, Bouzahzah B, Douglas SA, Shtutin V, Morris SA, Tsang E, Weiss LM, Christ GJ, Wittner M, Huang H, 2000. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infec-tion. Cardiovasc Pathol 9: 257-265.
40. Ashton AW, Mukherjee S, Nagajyothi FN, Huang H, Braunstein VL, Desruisseaux MS, Factor SM, Lopez L, Berman JW, Wittner M, Scherer PE, Capra V, Coffman TM, Serhan CN, Gotlinger K, Wu KK, Weiss LM, Tanowitz HB, 2007. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infec-tion. J Exp Med 204:929-940.